Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Inhalation of Tobramycin in CF Patients with Pseudomonas Aeruginosa
NCT00774072Phase 2Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Oct 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tobramycin in Pseudomonas aeruginosa infection, sponsored by Friedrich Schiller University Jena. Started Oct 2008; status: completed.
02
Drugs
tobramycin
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT00774072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00774072.